- Effect of Infliximab in the Treatment of Refractory Inflammatory Bowel Disease with Complication
-
Lee KM, Kim JS, Shin DH, Cheong JY, Yoo BM, Kim JK, Lee KJ, Hahm KB, Kim JH, Cho SW
- KMID: 772694
- Korean J Gastroenterol.
- 2004 Nov;44(5):259-266.
BACKGROUND/AIMS: Many studies on infliximab have confirmed its efficacy in the remission induction and even maintenance in refractory and fistulizing Crohn's disease. We report the treatment efficacy of infliximab... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study
-
Kim YS, Kim YH, Kim JS, Jeong SY, Park SJ, Cheon JH, Ye BD, Jung SA, Park YS, Choi CH, Kim KO, Jang BI, Han DS, Yang SK, Kim WH
- KMID: 2070082
- Gut Liver.
- 2014 Nov;8(6):643-647.
- doi: 10.5009/gnl13427
BACKGROUND/AIMS: Cytomegalovirus (CMV) reactivations are frequently observed in patients with active ulcerative colitis (UC), and ganciclovir therapy is effective in patients with steroid-refractory UC. This study aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
